Carmell Co. (NASDAQ:CTCX – Get Free Report) was the recipient of a significant growth in short interest in the month of December. As of December 31st, there was short interest totalling 827,600 shares, a growth of 688.2% from the December 15th total of 105,000 shares. Based on an average daily volume of 10,930,000 shares, the short-interest ratio is presently 0.1 days. Currently, 6.1% of the company’s stock are sold short.
Hedge Funds Weigh In On Carmell
An institutional investor recently bought a new position in Carmell stock. Warberg Asset Management LLC acquired a new stake in shares of Carmell Co. (NASDAQ:CTCX – Free Report) during the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 45,000 shares of the company’s stock, valued at approximately $60,000. Warberg Asset Management LLC owned 0.22% of Carmell at the end of the most recent quarter. Institutional investors and hedge funds own 24.22% of the company’s stock.
Carmell Price Performance
Shares of NASDAQ CTCX traded down $0.01 during trading on Wednesday, hitting $0.61. 529,198 shares of the company traded hands, compared to its average volume of 37,132,742. The business’s fifty day moving average is $0.32 and its 200 day moving average is $0.61. Carmell has a fifty-two week low of $0.20 and a fifty-two week high of $4.00.
Carmell Company Profile
Carmell Corporation operates as a bio-aesthetics company. The company utilizes Carmell Secretome to support skin and hair health. Its Carmell Secretome consists of growth factors and proteins extracted from allogeneic human platelets sourced from tissue banks. The company also developed a microemulsion formulation that enables delivery of lipophilic and hydrophilic ingredients without relying on the Foul Fourteen, 14 potentially harmful excipients that are commonly used by other companies to impart texture, stability, and other desirable physicochemical attributes to cosmetic products.
Further Reading
- Five stocks we like better than Carmell
- Best Aerospace Stocks Investing
- JPMorgan Chase & Co. Stock Can Hit $300 This Year
- What Is WallStreetBets and What Stocks Are They Targeting?
- What Goldman Sachs’ Quarterly Results Reveal About the Economy
- Investing in Commodities: What Are They? How to Invest in Them
- 3 Dividend Stocks at Bargain Levels to Defend Your Portfolio
Receive News & Ratings for Carmell Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Carmell and related companies with MarketBeat.com's FREE daily email newsletter.
